AVDL logo

Avadel Pharmaceuticals plc (AVDL) Stock Analysis

DELISTED 2026

What happened to Avadel Pharmaceuticals plc (AVDL) stock?

Avadel Pharmaceuticals plc (AVDL) no longer trades on public markets. It was delisted in February 2026. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
Delisting date:
February 2026
Last recorded price (historical):
$21.64 (last quote on record before the February 2026 delisting; historical, not a current quote)
MCap: $2.12B| P/E Ratio: 215.97| Vol: 35.02M| Target: $21.43 (Stored FMP targets · Captured Oct 7, 2026) (estimate, not advice)| 52-wk range: $6.38 – $23.57

P/E 215.97 means the share price is 215.97 times one year of earnings per share. Market cap $2.12B is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Avadel Pharmaceuticals plc (AVDL). Avadel Pharmaceuticals plc is a biopharmaceutical company headquartered in Dublin, Ireland, focused on developing and commercializing pharmaceutical products in the United States.

Last analyzed: Jun 13, 2026
Avadel Pharmaceuticals plc is a biopharmaceutical company headquartered in Dublin, Ireland, focused on developing and commercializing pharmaceutical products in the United States. Its primary asset is FT218, a novel formulation of sodium oxybate, currently undergoing Phase 3 clinical trials for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy.

These figures come from statements filed 13 months ago — the most recent this company has published.

Avadel Pharmaceuticals plc (AVDL) Healthcare & Pipeline Overview

Model self-rating on this text: 69% (not a measure of the evidence) Updated: Jun 13, 2026

Avadel Pharmaceuticals plc ADR Information Sponsored

Avadel Pharmaceuticals plc (AVDL) trades in the U.S. as an American Depositary Receipt (ADR).

  • ADR Level: 2
  • ADR Ratio: 1:1

More about this archive record

Can I still buy AVDL shares?

No. AVDL stopped trading on public markets in February 2026, so the shares are not available through a broker. Anything you see quoted for AVDL elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before AVDL stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Avadel Pharmaceuticals plc. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.